Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Iannitto

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|March 21, 2015
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II studyEmilio Iannitto, Stefano Luminari, Claudio Tripodo, et al.
British Journal of Haematology|November 22, 2012
Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphomaGaetano Corazzelli, Francesco Angrilli, Alfonso D'Arco, et al.
Leukemia & Lymphoma|February 9, 2011
Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized studyGiovanni D'Arena, Paolo G Gobbi, Chiara Broglia, et al.
Blood|December 3, 2003
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical studyAndrea Gallamini, Caterina Stelitano, Roberta Calvi, et al.
Blood|April 26, 2003
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control studyAlfonso Mele, Alessandro Pulsoni, Elvira Bianco, et al.
The New Microbiologica|September 7, 2007
Rare HVR1-HCV genotype 1b variants in patients with B non Hodgkin's lymphoma. Comparison with viral sequences detected in cases of lymphoproliferative disorders and B cell compartmentalisationStefano Dettori, Claudio Argentini, Fabrizio Marcucci, et al.
Haematologica|April 6, 2006
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphomaFabrizio Marcucci, Alfonso Mele, Enea Spada, et al.
Haematologica|February 3, 2004
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control studyElvira Bianco, Fabrizio Marcucci, Alfonso Mele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi TrialMassimo Federico, Stefano Luminari, Emilio Iannitto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2007
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish studyAndrea Gallamini, Martin Hutchings, Luigi Rigacci, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|March 21, 2015
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II studyEmilio Iannitto, Stefano Luminari, Claudio Tripodo, et al.
British Journal of Haematology|November 22, 2012
Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphomaGaetano Corazzelli, Francesco Angrilli, Alfonso D'Arco, et al.
Leukemia & Lymphoma|February 9, 2011
Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized studyGiovanni D'Arena, Paolo G Gobbi, Chiara Broglia, et al.
Blood|December 3, 2003
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical studyAndrea Gallamini, Caterina Stelitano, Roberta Calvi, et al.
Blood|April 26, 2003
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control studyAlfonso Mele, Alessandro Pulsoni, Elvira Bianco, et al.
The New Microbiologica|September 7, 2007
Rare HVR1-HCV genotype 1b variants in patients with B non Hodgkin's lymphoma. Comparison with viral sequences detected in cases of lymphoproliferative disorders and B cell compartmentalisationStefano Dettori, Claudio Argentini, Fabrizio Marcucci, et al.
Haematologica|April 6, 2006
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphomaFabrizio Marcucci, Alfonso Mele, Enea Spada, et al.
Haematologica|February 3, 2004
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control studyElvira Bianco, Fabrizio Marcucci, Alfonso Mele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi TrialMassimo Federico, Stefano Luminari, Emilio Iannitto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2007
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish studyAndrea Gallamini, Martin Hutchings, Luigi Rigacci, et al.
Pageof 7